Top Markets
#1 Black Phoenix Black Phoenix +860.56%
#2 QuantixAI QuantixAI +102.43%
#3 Nesa Nesa +39.29%
#4 MetaDAO MetaDAO +26.15%
#5 Pons Pons +23.30%
#6 LayerZero LayerZero +20.52%
#7 Bedrock Bedrock +19.99%
#8 Ontology Gas Ontology Gas +15.42%
#9 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +15.08%
#10 Prom Prom +14.96%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Rang in aandelen #2339
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Aandeelprijs
$43.48
Marktkapitalisatie
$8.97B
Verandering (1 dag)
0.37%
Verandering (1 jaar)
192.01%
Land
US
Handel Immunovant, Inc. (IMVT)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Immunovant, Inc. (IMVT)
Het dividendrendement (TTM) van Immunovant, Inc. (aandelsymbool: IMVT) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Immunovant, Inc. (IMVT) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH